Friday, 31 Oct 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • đŸ”¥
  • Trump
  • VIDEO
  • House
  • White
  • ScienceAlert
  • Trumps
  • Watch
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Economy > Novo Nordisk reports second quarter earnings missing Wall Street estimates on slower GLP-1 sales
Economy

Novo Nordisk reports second quarter earnings missing Wall Street estimates on slower GLP-1 sales

Last updated: August 6, 2025 4:05 am
Share
Novo Nordisk reports second quarter earnings missing Wall Street estimates on slower GLP-1 sales
SHARE

Novo Nordisk (NVO) stock took a hit in pre-market trading after the company reported a miss on both top and bottom lines of its second-quarter earnings. This news comes on the heels of a recent announcement by the company of a downward revision in its 2025 guidance.

While Novo Nordisk narrowly missed revenue expectations, reporting $11.95 billion compared to the anticipated $11.97 billion, it also fell short on earnings per share (EPS), coming in at $5.96 versus the estimated $6.06 per share. Despite this, the company saw a 16% increase in sales year over year, with its two blockbuster drugs, Ozempic and Wegovy, contributing $7.9 billion to the total revenue for the quarter.

The company’s growth has been dampened by the proliferation of compounded weight loss drugs that mimic its semaglutide ingredient. Novo Nordisk has taken legal action against these copycat versions, filing a total of 132 lawsuits in 40 states, with 14 new suits announced just last week.

Outgoing CEO Lars Jørgensen pointed to the impact of these unauthorized versions of their drugs on the company’s growth trajectory, noting that over one million patients are using these knockoff medications. He highlighted concerns about the quality control and lack of FDA approval for these products, which are primarily produced in China.

In addition to the competition from copycat drugs, Novo Nordisk faces challenges from rival pharmaceutical company Eli Lilly, whose new patient prescriptions have surpassed 60%. Despite securing a deal with CVS to be the exclusive weight loss drug on its formulary, Novo’s drugs, including Ozempic, will face pricing negotiations for Medicare next year.

See also  Nvidia executives cash out $1bn worth of shares

Adding to the company’s woes, President Donald Trump recently sent a letter to Novo Nordisk and 16 other companies demanding that they provide their lowest prices offered to developing countries to the Medicaid population. Jørgensen defended the company’s pricing, stating that Medicaid enrollees already receive some of the lowest prices compared to Europe.

While Novo Nordisk has not responded directly to Trump’s demand for lower cash pricing for all patients, the company’s direct-to-consumer platform, NovoCare, has seen a 10% market penetration since its launch in March.

Despite these challenges, Novo Nordisk remains committed to navigating the complex landscape of the pharmaceutical industry. As the company continues to address competition, pricing pressures, and legal battles, investors will be closely watching to see how Novo Nordisk adapts and evolves in the ever-changing healthcare market.

TAGGED:EarningsestimatesGLP1MissingNordiskNovoquarterReportsSalesslowerStreetWall
Share This Article
Twitter Email Copy Link Print
Previous Article Repair or Replace: Which Is Best For You And The Environment? Repair or Replace: Which Is Best For You And The Environment?
Next Article Tennessee 911 caller breaks silence after helping police capture fugitive felon Austin Drummond accused of murdering family Tennessee 911 caller breaks silence after helping police capture fugitive felon Austin Drummond accused of murdering family
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

Sprouts Farmers Market, Inc. (SFM) Expansion Gathers Pace with New Florida Store

Sprouts Farmers Market Inc. (NASDAQ: SFM) continues to emerge as one of the top FMCG…

September 26, 2025

45 years for man who slashed DePaul grad’s throat on Lincoln Park campus

The Conviction of Adam Bramwell: A Recap of the Crime Spree Adam Bramwell, a four-time…

September 19, 2025

Banijay Kids & Family Secures Sales for ‘Once Upon a Time…,’ Demonstrating Its ‘Sustained Relevance and Appeal on a Global Scale’

Banijay Kids & Family, the force behind popular series like “Totally Spies!” and “Mr. Bean:…

October 12, 2025

Affirm launches in the UK, as ‘buy now, pay later’ market faces regulatory overhaul

Introducing Affirm: The BNPL Giant Launching in the U.K. Affirm, the buy now, pay later…

November 3, 2024

Alexis Bledel, Elisabeth Moss and More

The Emmy Awards rulebook is a sacred document in the world of television, but recent…

May 27, 2025

You Might Also Like

Market analysts react to Trump-Xi meet
Economy

Market analysts react to Trump-Xi meet

October 31, 2025
29 truck carrier files Chapter 11
Economy

29 truck carrier files Chapter 11

October 31, 2025
Trust Government Statistics, Not Government
Economy

Trust Government Statistics, Not Government

October 31, 2025
Jefferies Raises BP Price Target to 420 GBp, Maintains Hold Rating
Economy

Jefferies Raises BP Price Target to 420 GBp, Maintains Hold Rating

October 31, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?